We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMS icon
626
Advanced Drainage Systems
WMS
$10.8B
-10,766
Closed -$317K
WPC icon
627
W.P. Carey
WPC
$15.9B
-592
Closed -$34K
WRB icon
628
W.R. Berkley
WRB
$26B
-1,076
Closed -$25K
WWD icon
629
Woodward
WWD
$21.1B
-1,040
Closed -$62K
WY icon
630
Weyerhaeuser
WY
$18B
-13,402
Closed -$227K
ZION icon
631
Zions Bancorporation
ZION
$10.4B
-4,914
Closed -$131K
TXNM
632
TXNM Energy Inc
TXNM
$5.91B
-1,679
Closed -$64K
BERY
633
DELISTED
Berry Global Group, Inc.
BERY
-10,406
Closed -$322K
NVRO
634
DELISTED
NEVRO CORP.
NVRO
-199
Closed -$20K
PACW
635
DELISTED
PacWest Bancorp
PACW
-43
Closed -$1K
SYNH
636
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-4,346
Closed -$171K
BKI
637
DELISTED
Black Knight, Inc. Common Stock
BKI
-469
Closed -$27K
ABMD
638
DELISTED
Abiomed Inc
ABMD
-436
Closed -$63K
CLR
639
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$0 ﹤0.01%
1
-7,527
-100% -$106K
CCXI
640
DELISTED
ChemoCentryx, Inc.
CCXI
-3,647
Closed -$147K
TMX
641
DELISTED
Terminix Global Holdings, Inc.
TMX
-1,759
Closed -$47K
MNDT
642
DELISTED
Mandiant, Inc. Common Stock
MNDT
-6,868
Closed -$73K
ZNGA
643
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-22,252
Closed -$152K
ISBC
644
DELISTED
Investors Bancorp, Inc.
ISBC
-11,401
Closed -$91K
NUAN
645
DELISTED
Nuance Communications, Inc.
NUAN
-11,573
Closed -$194K
INOV
646
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-3,657
Closed -$61K
PRAH
647
DELISTED
PRA Health Sciences, Inc.
PRAH
-1,022
Closed -$85K
NAV
648
DELISTED
Navistar International
NAV
-16,883
Closed -$278K
GRUB
649
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
-69
Closed -$6K
CLGX
650
DELISTED
Corelogic, Inc.
CLGX
-3,157
Closed -$96K

Similar funds

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.